Background and objective: The uptake of new medicines is slower in the UK than in many
other countries. Previous research found that cost and price have little influence on general …

Summary Background and Objective: The rate of uptake of new medicines in the UK is
slower than in many other OECD countries. The majority of new medicines are introduced …

Background. Prescribing varies considerably between GPs, and a minority of GPs account
for a large proportion of new drug prescribing. Objective. Our aim was to explore the …

BACKGROUND: Ensuring appropriate prescribing is an important challenge for the health
service, and the need for research that takes account of the reasons behind individual …

Objective: To explore consultants9 and general practitioners9 perceptions of the factors that
influence their decisions to introduce new drugs into their clinical practice. Design …

Background Medical specialists are often seen as the first prescribers of new drugs.
However, the extent to which specialists influence new drug prescribing in primary care is …

Objectives. The aim of this study was to understand the range of factors that influence GPs'
uptake of new drugs Methods. A total of 107 GPs selected purposively from high, medium …

BACKGROUND: The aim of this study was to identify the factors that influence prescribing of
new drugs among general practitioners, endocrinologists and psychiatrists. METHODS: Four …

Objective In recent years prescribing rights have been extended beyond doctors and
dentists in the UK, first to nurses and subsequently to pharmacists. The aim of the study was …

Background: General practitioner (GP) prescribing accounts for about 10% of NHS
expenditure. GPs at the top of the range have annual prescribing costs that are almost twice …